Retraction

VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1155/2022/9851919
Additional Notes:

See also: https://pubpeer.com/publications/6ADF69D955F55E10598BAC956D1436

Citations (14)

14
Total Citations
9
Post-Retraction
(64.3%)
4
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
4 Within 1 year
3 After 2+ years
1173 Days since retraction (latest)
<b>Exploring</b> Hippo YAP/TAZ Signaling: A Novel Avenue for Cardiovascular Disorders
Arwa Mithaiwala, Angel Godad
Cell Biology International
Published: Jul 2025
1173 days after retraction
The Evaluation of <scp><i>PNPLA2</i></scp>, <scp>ATGL</scp>, and <scp>G0S2</scp> Levels in Serum and <scp>PBMCs</scp> of the Newly Diagnosed and the Chronic Patients With Rheumatoid Arthritis
Masoomeh Gholizadeh, Jahanbakhsh Asadi, Mehrdad Aghaei et al. (7 authors)
International Journal of Rheumatic Diseases
Published: Feb 2025
1010 days after retraction
Sex differences in the association between composite dietary antioxidant index and hyperlipidemia: Insights from NHANES
Xiaofan Miao, Bixia Li, Zhixian Zhu et al. (4 authors)
PLoS ONE Open Access
Published: Jan 2025
3 citations
988 days after retraction
Research Progress and Molecular Mechanisms of Endothelial Cells Inflammation in Vascular-Related Diseases
Jiaojiao Xue, Ziwei Zhang, Yuting Sun et al. (10 authors)
Journal of Inflammation Research Open Access
Published: Aug 2023
21 citations
460 days after retraction
Plasma-derived exosomal let-7c-5p, miR-335–3p, and miR-652–3p as potential diagnostic biomarkers for stable coronary artery disease
Jian Han, Xiaogang Cui, Tianqi Yuan et al. (8 authors)
Frontiers in Physiology Open Access
Published: May 2023
7 citations
376 days after retraction
The role of 14-3-3 in the progression of vascular inflammation induced by lipopolysaccharide
Hongwei Tan, Jin‐Ping Li, Chunsen Jia et al. (9 authors)
International Immunopharmacology Open Access
Published: Apr 2023
3 citations
362 days after retraction
Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases
Ruojun Li, Weiqiang Huang
International Journal of Molecular Sciences Open Access
Published: Jan 2023
9 citations
261 days after retraction
The regulation of yes-associated protein/transcriptional coactivator with PDZ-binding motif and their roles in vascular endothelium
Wen Zhang, Qianqian Li, Hanyi Gao et al. (6 authors)
Frontiers in Cardiovascular Medicine Open Access
Published: Jul 2022
8 citations
85 days after retraction
Hippo: A New Hub for Atherosclerotic Disease
Xi-Yan Liu, Kun Zhou, Kai-Jiang Tian et al. (8 authors)
Current Pharmaceutical Design
Published: Apr 2022
2 citations
2 days after retraction
Retracted: VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway
Mediators Of Inflammation
Mediators of Inflammation Open Access
Published: Apr 2022
Same day as retraction
Exosomes Derived from Mesenchymal Stem Cells Ameliorate the Progression of Atherosclerosis in ApoE−/− Mice via FENDRR
Nan Zhang, Yuxin Luo, Huaping Zhang et al. (6 authors)
Cardiovascular Toxicology
Published: Mar 2022
16 citations
32 days before retraction
Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea
Maohua Wang, Ying Dong, Song Gao et al. (14 authors)
Cellular and Molecular Life Sciences Open Access
Published: Jan 2022
49 citations
99 days before retraction
Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions
Phatchanat Klaihmon, Chanchao Lorthongpanich, Pakpoom Kheolamai et al. (5 authors)
Biomedicines Open Access
Published: Jan 2022
3 citations
107 days before retraction
Yes-Associated Protein in Atherosclerosis and Related Complications: A Potential Therapeutic Target That Requires Further Exploration
Congrui Sun, Bin He, Mingsheng Sun et al. (10 authors)
Frontiers in Cardiovascular Medicine Open Access
Published: Aug 2021
10 citations
244 days before retraction
Quick Stats
Total Citations: 14
Years Since Retraction: 3.5 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Expression of CD62P and CD154 in peripheral blood of patien…
European Journal of Inflammation • 0 citations
microRNA-29b prevents renal fibrosis by attenuating renal t…
International Urology and Nephrology • 32 citations
lncRNA BZRAP1-AS1 Alleviates Rheumatoid Arthritis by Regula…
Immunity, Inflammation and Disease • 17 citations
LncRNA NEAT1 Targets MiR-125/ADAM9 Mediated NF-κB Pathway i…
Skin Research and Technology • 4 citations
MiR-92b-3p ameliorates inflammation and autophagy by target…
International Immunopharmacology • 24 citations